Total Payments
$578,369
2024 Payments
$479.26
Companies
21
Transactions
784
Medicare Patients
3,210
Medicare Billing
$491,213
Payment Breakdown by Category
Other$398,567 (68.9%)
Travel$91,772 (15.9%)
Consulting$69,530 (12.0%)
Food & Beverage$18,478 (3.2%)
Education$22.05 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $394,236 | 139 | 68.2% |
| Travel and Lodging | $91,772 | 319 | 15.9% |
| Consulting Fee | $69,530 | 26 | 12.0% |
| Food and Beverage | $18,478 | 296 | 3.2% |
| Honoraria | $4,331 | 1 | 0.7% |
| Education | $22.05 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $229,880 | 269 | $0 (2018) |
| Amarin Pharma Inc. | $90,015 | 134 | $0 (2017) |
| Amgen Inc. | $78,177 | 127 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $64,551 | 79 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $48,996 | 73 | $0 (2024) |
| ARALEZ PHARMACEUTICALS US INC. | $46,716 | 56 | $0 (2018) |
| Daiichi Sankyo Inc. | $7,169 | 10 | $0 (2018) |
| Esperion Therapeutics, Inc. | $6,194 | 7 | $0 (2024) |
| Aegerion Pharmaceuticals, Inc. | $4,370 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $1,199 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $479.26 | 7 | Regeneron Healthcare Solutions, Inc. ($287.66) |
| 2023 | $68.78 | 4 | Novo Nordisk Inc ($24.10) |
| 2022 | $3,568 | 7 | Amgen Inc. ($3,526) |
| 2020 | $17,948 | 25 | Amgen Inc. ($11,769) |
| 2019 | $34,231 | 65 | Amgen Inc. ($27,821) |
| 2018 | $191,086 | 242 | Kowa Pharmaceuticals America, Inc. ($116,175) |
| 2017 | $330,989 | 434 | Kowa Pharmaceuticals America, Inc. ($113,705) |
All Payment Transactions
784 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $139.30 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/10/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $121.12 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $133.88 | General |
| Category: Inflammation | ||||||
| 01/11/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/24/2023 | Amryt Pharma Holdings Ltd | Juxtapid (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.10 | General |
| 09/19/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/17/2022 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $149.76 | General |
| Category: Cardiology | ||||||
| 03/17/2022 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $3.00 | General |
| Category: Cardiology | ||||||
| 03/15/2022 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 03/15/2022 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 03/09/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $106.50 | General |
| Category: Cardiology | ||||||
| 12/22/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/22/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/18/2020 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $218.50 | General |
| Category: Cardiology | ||||||
| 12/18/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Cardiology | ||||||
| 12/18/2020 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $10.70 | General |
| Category: Cardiology | ||||||
| 12/18/2020 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $6.00 | General |
| Category: Cardiology | ||||||
| 12/17/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $924.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 693 | 882 | $199,266 | $104,152 |
| 2022 | 15 | 708 | 932 | $201,501 | $108,509 |
| 2021 | 14 | 739 | 1,032 | $215,987 | $118,674 |
| 2020 | 21 | 1,070 | 1,480 | $296,307 | $159,877 |
Total Patients
3,210
Total Services
4,326
Medicare Billing
$491,213
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 185 | 186 | $56,355 | $25,742 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 232 | $31,784 | $21,049 | 66.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 119 | 119 | $32,338 | $16,227 | 50.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 67 | 68 | $22,554 | $11,975 | 53.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 19 | 38 | $9,880 | $7,746 | 78.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 19 | 19 | $13,433 | $5,913 | 44.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 40 | 40 | $11,202 | $4,773 | 42.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 51 | 51 | $8,252 | $4,376 | 53.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,024 | $1,740 | 57.5% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 16 | 16 | $2,546 | $1,635 | 64.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 17 | 19 | $3,345 | $1,455 | 43.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 19 | 19 | $2,033 | $901.36 | 44.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 54 | 63 | $2,520 | $620.40 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 181 | 182 | $55,226 | $25,348 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 196 | $26,852 | $18,325 | 68.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 115 | 117 | $32,138 | $16,888 | 52.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 59 | 59 | $20,577 | $11,032 | 53.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 24 | 24 | $16,968 | $8,353 | 49.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 24 | 48 | $10,716 | $8,277 | 77.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 20 | 80 | $7,200 | $3,872 | 53.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 42 | 43 | $6,921 | $3,769 | 54.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 26 | 26 | $7,146 | $3,765 | 52.7% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2022 | 24 | 24 | $3,756 | $2,509 | 66.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 14 | 14 | $3,920 | $1,922 | 49.0% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 20 | 20 | $3,468 | $1,624 | 46.8% |
About Dr. Dean Bramlet, MD
Dr. Dean Bramlet, MD is a Specialist healthcare provider based in Pinellas Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164536488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Bramlet, MD has received a total of $578,369 in payments from pharmaceutical and medical device companies, with $479.26 received in 2024. These payments were reported across 784 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($394,236).
As a Medicare-enrolled provider, Bramlet has provided services to 3,210 Medicare beneficiaries, totaling 4,326 services with total Medicare billing of $491,213. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Pinellas Park, FL
- Active Since 08/17/2006
- Last Updated 12/08/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164536488
Products in Payments
- Livalo (Drug) $225,074
- Vascepa (Drug) $90,015
- Repatha (Biological) $77,943
- PRALUENT (Drug) $60,086
- PRALUENT ALIROCUMAB INJECTION (Biological) $48,203
- ZONTIVITY (Drug) $24,301
- YOSPRALA (Drug) $22,415
- Welchol (Drug) $7,169
- NEXLIZET (Drug) $6,179
- DISEASE STATE (Drug) $4,465
- JUXTAPID (Drug) $4,370
- FARXIGA (Drug) $1,074
- PRALUENT (Biological) $566.11
- EVKEEZA (Biological) $301.54
- Synthroid (Drug) $229.96
- Otezla (Drug) $133.88
- BRILINTA (Drug) $124.99
- XARELTO (Drug) $120.83
- Mitra Clip system (Device) $119.86
- WATCHMAN (Device) $110.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pinellas Park
Dr. Harish Patel, M.d, M.D
Specialist — Payments: $6,926
Specialist $6,926
Dr. Venkata Iyunni, Md, MD
Specialist — Payments: $649.09
Specialist $649.09
Dr. Jeng Lin, Md, MD
Specialist — Payments: $221.77
Specialist $221.77
Mrs. Tamara Kennedy, Pt, PT
Specialist
Specialist
Mr. Bradley Young
Specialist
Specialist
Mr. Algis Meilus, Specialist, SPECIALIST
Specialist
Specialist